(ECNS) – A nucleic acid reagent to test the deadly Ebola virus has been developed in China, according to people.cn on Thursday.
An application for urgent examination and approval of the reagent has been submitted to China Food and Drug Administration (CFDA).
The reagent is co-developed by BGI, a Shenzhen-based gene company and the Institute of Microbiology Epidemiology at Academy of Military Medical Sciences.
BGI has participated in completing China's first genome sequence of SARS virus and developing H7N9 diagnostic reagent.
Though the virus has not spread to China and possibility of an Ebola outbreak is extremely low, the reagent is still essential for prevention, said a researcher with the project.
Ebola, mainly spreading through body fluids or secretions of the inflected, is believed to be very difficult to control.
Over 1,069 people have reportedly died from the virus with 1,975 infected in the West Africa by August 11.
联系客服
